Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-Blockers Combined With Neoadjuvant Immunotherapy for Locally Advanced Gastric Cancer
NCT07511894Phase 2Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metoprolol in gastric cancer (GC), sponsored by Nanfang Hospital, Southern Medical University. Planned start May 2026; status: not yet recruiting.
02
Drugs
metoprolol
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07511894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511894.